These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12934103)

  • 1. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor.
    Di Bacco A; Gill G
    Oncogene; 2003 Aug; 22(35):5436-45. PubMed ID: 12934103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts.
    Han YL; Guo P; Sun MY; Guo L; Luan B; Kang J; Yan CH; Li SH
    Genes Cells; 2008 Sep; 13(9):977-86. PubMed ID: 18691225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic modulation of vascular smooth muscle cells.
    Han Y; Luan B; Sun M; Guo L; Guo P; Tao J; Deng J; Wu G; Liu S; Yan C; Li S
    J Mol Cell Cardiol; 2011 Apr; 50(4):723-30. PubMed ID: 21195083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.
    Han Y; Cui J; Tao J; Guo L; Guo P; Sun M; Kang J; Zhang X; Yan C; Li S
    Exp Cell Res; 2009 Nov; 315(19):3301-11. PubMed ID: 19769965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells.
    Veal E; Groisman R; Eisenstein M; Gill G
    Oncogene; 2000 Apr; 19(17):2120-8. PubMed ID: 10815803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of CREG, a secreted glycoprotein involved in cellular growth and differentiation.
    Sacher M; Di Bacco A; Lunin VV; Ye Z; Wagner J; Gill G; Cygler M
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18326-31. PubMed ID: 16344469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular repressor of E1A-stimulated genes mediates glucocorticoid-induced loss of the type-2 IGF receptor in ileal epithelial cells.
    Gordon PV; Paxton JB; Fox NS
    J Endocrinol; 2005 May; 185(2):265-73. PubMed ID: 15845919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
    Kang JX; Bell J; Beard RL; Chandraratna RA
    Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-2/mannose-6 phosphate receptors.
    El-Shewy HM; Luttrell LM
    Vitam Horm; 2009; 80():667-97. PubMed ID: 19251055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.
    Hébert E
    Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.
    Martin-Kleiner I; Gall Troselj K
    Cancer Lett; 2010 Mar; 289(1):11-22. PubMed ID: 19646808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced posttranscriptional control of M6P/IGF2r expression in breast cancer cell lines.
    Iwamoto KS; Barber CL
    Mol Carcinog; 2007 Jul; 46(7):497-502. PubMed ID: 17295243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose-6-phosphate/insulin-like growth factor-II receptor in human melanoma cells: effect of ligands and antibodies on the receptor expression.
    Laube F
    Anticancer Res; 2009 Apr; 29(4):1383-8. PubMed ID: 19414391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
    Mills JJ; Falls JG; De Souza AT; Jirtle RL
    Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.
    Hawkes C; Kar S
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):117-40. PubMed ID: 15003389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
    J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.